<DrugInformationSummary id="CDR0000818002"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>This page contains brief information about penpulimab-kcqx
         and a collection of links to more information about the use of 
         this drug, research results, and ongoing clinical trials.
  </DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/penpulimab-kcqx">Penpulimab-kcqx</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000794779">penpulimab-kcqx</TerminologyLink><GlossaryLink ref="CDR0000818022">penpulimab</GlossaryLink><PronunciationInfo><TermPronunciation>pen-PUH-lih-mab</TermPronunciation></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=830004e8-31af-4cc6-ab16-e870cab1c5ca&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Penpulimab-kcqx</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=830004e8-31af-4cc6-ab16-e870cab1c5ca&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Penpulimab-kcqx
         is approved to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000445072" dictionary="Cancer.gov" audience="Patient">Nasopharyngeal carcinoma</GlossaryTermRef></Strong> (a type of <GlossaryTermRef href="CDR0000257519" dictionary="Cancer.gov" audience="Patient">head and neck cancer</GlossaryTermRef>). It is used in adults whose cancer does not form masses of cells that contain <GlossaryTermRef href="CDR0000721317" dictionary="Cancer.gov" audience="Patient">keratin</GlossaryTermRef>. It is given:<ItemizedList Style="bullet" id="_4"><ListItem>with <GlossaryTermRef href="CDR0000508951" dictionary="Cancer.gov" audience="Patient">gemcitabine hydrochloride</GlossaryTermRef> and either <GlossaryTermRef href="CDR0000045230" dictionary="Cancer.gov" audience="Patient">cisplatin</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045182" dictionary="Cancer.gov" audience="Patient">carboplatin</GlossaryTermRef> as the first treatment in patients whose cancer has spread to other parts of the body or has come back</ListItem><ListItem>alone in patients whose cancer has spread to other parts of the body and got worse during or after treatment with <GlossaryTermRef href="CDR0000045841" dictionary="Cancer.gov" audience="Patient">platinum</GlossaryTermRef>-based chemotherapy and at least one other therapy</ListItem></ItemizedList></ListItem>
   
   </ItemizedList>
  <Para id="_5">Penpulimab-kcqx
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Penpulimab-kcqx</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794779">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies">Monoclonal Antibodies</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors">Immune Checkpoint Inhibitors</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C155879">Find Clinical Trials for Penpulimab-kcqx</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2025-05-07</DateFirstPublished></DrugInformationSummary>
